Sweden
· Delayed Price · Currency is SEK SpectraCure AB Statistics
Total Valuation
SpectraCure AB has a market cap or net worth of SEK 78.68 million. The enterprise value is 65.55 million.
| Market Cap | 78.68M |
| Enterprise Value | 65.55M |
Important Dates
The next estimated earnings date is Friday, May 16, 2025.
| Earnings Date | May 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SpectraCure AB has 97.13 million shares outstanding.
| Current Share Class | 97.13M |
| Shares Outstanding | 97.13M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -7.18% |
| Owned by Insiders (%) | 26.95% |
| Owned by Institutions (%) | 12.80% |
| Float | 70.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.85 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.99 |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.93 |
| Quick Ratio | 1.93 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.23 |
| Interest Coverage | -49.26 |
Financial Efficiency
Return on equity (ROE) is -19.44% and return on invested capital (ROIC) is -11.59%.
| Return on Equity (ROE) | -19.44% |
| Return on Assets (ROA) | -10.84% |
| Return on Invested Capital (ROIC) | -11.59% |
| Return on Capital Employed (ROCE) | -21.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.77M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.81% in the last 52 weeks. The beta is 0.42, so SpectraCure AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -72.81% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 2.03 |
| Relative Strength Index (RSI) | 24.54 |
| Average Volume (20 Days) | 233,429 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | 9.77M |
| Operating Income | -23.06M |
| Pretax Income | -23.01M |
| Net Income | -23.00M |
| EBITDA | -20.42M |
| EBIT | -23.06M |
| Earnings Per Share (EPS) | -0.24 |
Balance Sheet
The company has 18.27 million in cash and 5.15 million in debt, giving a net cash position of 13.13 million or 0.14 per share.
| Cash & Cash Equivalents | 18.27M |
| Total Debt | 5.15M |
| Net Cash | 13.13M |
| Net Cash Per Share | 0.14 |
| Equity (Book Value) | 106.86M |
| Book Value Per Share | 1.10 |
| Working Capital | 10.70M |
Cash Flow
In the last 12 months, operating cash flow was -21.83 million and capital expenditures -130,000, giving a free cash flow of -21.96 million.
| Operating Cash Flow | -21.83M |
| Capital Expenditures | -130,000 |
| Free Cash Flow | -21.96M |
| FCF Per Share | -0.23 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SpectraCure AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -29.24% |
| FCF Yield | -27.91% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |